Biora Therapeutics, Inc.
Biora Therapeutics, Inc. (BIOR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BIOR · as of Jun 9, 2026
Key Statistics
Explore Biora Therapeutics, Inc. Data
bior stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
bior competitorsBIOR
BPTH
CAIHF
EDXC
EPGNF
EVFMStock Performance
Full HistoryAbout Biora Therapeutics, Inc.
Biora Therapeutics, Inc. is a biotechnology company focused on developing cutting-edge oral biotherapeutic solutions. The company's core efforts involve two main therapeutic programs: Targeted Therape…
what is biora therapeutics, inc. · bior stock overview · biora therapeutics, inc. company profile · who is biora therapeutics, inc. ceo · bior OTC · biora therapeutics, inc. headquarters · biora therapeutics, inc. business segments
About Stock Overview & Key Data
Biora Therapeutics, Inc. (BIOR) is a Healthcare company in the Biotechnology industry, listed on OTC since Jun 19, 2020. As of the latest trading session, BIOR stock price is $0.22, with a market capitalization of $994,994. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Biora Therapeutics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2023, Biora Therapeutics, Inc. reported revenue of $4000.00 and net income of -$124.1M. For detailed data — including Biora Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Biora Therapeutics, Inc. (BIOR) stock price is $0.22. The stock is traded on OTC under the ticker symbol BIOR. The 52-week range is $0.15 – $0.38.